Article

Newly cleared biometer twice as fast as previous platforms

The FDA has approved a new biometer (IOLMaster 500, Carl Zeiss Meditec) to calculate eye measurements for lens selection related to cataract surgery.

Dublin, CA-The FDA has approved a new biometer (IOLMaster 500, Carl Zeiss Meditec) to calculate eye measurements for lens selection related to cataract surgery.

The device has dual measurement capabilities, composite signal filtering, and user-interface advancements, according to the manufacturer, making it twice as fast as previous platforms and increasing the percentage of eyes it can measure, including those of patients who have dense cataracts.

When introduced a decade ago, this biometer was the first automatic biometry system available that did not make contact with the patient’s eye, the manufacturer reports. More than 11,000 units exist in the world today.

“The newest and most advanced [model] . . . incorporates new algorithms and user-friendly enhancements, resulting in greater efficiency, clinical accuracy, and overall performance,” said Ludwin Monz, chief executive officer of Carl Zeiss Meditec.

Advanced capabilities of the new biometer:

  • Increased speed. In individual practice studies, the new device has been shown to complete all measurements in as few as 80 seconds.
  • Dual-mode measurements. Axial length and keratometry calculations can be collected simultaneously, at the push of a button.
  • Composite signal filtering. New sound-filtering technology excludes poor readings and increases the percentage of cataract patients that can be measured.
  • Seamless data integration. This feature allows workflow integration of A-scan ultrasound biometry for difficult cases, such as extremely dense cataracts.
  • Data transfer to the Holladay Consultant program.
  • New graphical user interface. Green, red, and yellow “traffic light” reporting is designed to allow technicians of all experience levels to achieve highly accurate diagnostic results.

Newsletter

Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.

Related Videos
Lisa Nijm, MD, says preoperative osmolarity testing can manage patient expectations and improve surgical results at the 2025 ASCRS annual meeting
At the 2025 ASCRS Annual Meeting, Weijie Violet Lin, MD, ABO, shares highlights from a 5-year review of cross-linking complications
Maanasa Indaram, MD, is the medical director of the pediatric ophthalmology and adult strabismus division at University of California San Francisco, and spoke about corneal crosslinking (CXL) at the 2025 ASCRS annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Taylor Strange, DO, assesses early visual outcomes with femto-created arcuate incisions in premium IOL cases
(Image credit: Ophthalmology Times) ASCRS 2025: Neda Shamie, MD, shares her early clinical experience with the Unity VCS system
Patricia Buehler, MD, MPH, founder and CEO of Osheru, talks about the Ziplyft device for noninvasive blepharoplasty at the 2025 American Society of Cataract and Refractive Surgeons (ASCRS) annual meeting
(Image credit: Ophthalmology Times) ASCRS 2025: Bonnie An Henderson, MD, on leveraging artificial intelligence in cataract refractive surgery
(Image credit: Ophthalmology Times) ASCRS 2025: Gregory Moloney, FRANZO, FRCSC, on rotational stability
Sheng Lim, MD, FRCOphth, discusses the CONCEPT study, which compared standalone cataract surgery to cataract surgery with ECP, at the 2025 ASCRS Annual Meeting.
(Image credit: Ophthalmology Times) ASCRS 2025: Steven J. Dell, MD, reports 24-month outcomes for shape-changing IOL
© 2025 MJH Life Sciences

All rights reserved.